---
title: "12 Health Care Stocks Moving In Monday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294691850.md"
description: "In Monday's pre-market session, healthcare stocks showed significant volatility. Universe Pharmaceuticals surged 121.2% to $6.99, while Supernus Pharmaceuticals rose 16.28% following its Q2 earnings report. Other gainers included Neuraxis, cbdMD, Faeth Therapeutics, and Mobile-health Network. Conversely, Cumberland Pharma declined 21.0%, with Genprex, Shuttle Pharmaceuticals, Galmed Pharmaceuticals, VSee Health, and Autonomix Medical also posting losses."
datetime: "2026-08-03T12:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294691850.md)
  - [en](https://longbridge.com/en/news/294691850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294691850.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Pre-Market Session

### Gainers

-   **Universe Pharmaceuticals** (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million.
-   **Supernus Pharmaceuticals** (NASDAQ:SUPN) shares moved upwards by 16.28% to $51.9. The company's market cap stands at $2.4 billion. As per the news, the Q2 earnings report came out today.
-   **Neuraxis** (AMEX:NRXS) shares rose 15.51% to $7.22. The market value of their outstanding shares is at $77.9 million.
-   **cbdMD** (AMEX:YCBD) shares moved upwards by 11.46% to $0.56. The company's market cap stands at $5.3 million.
-   **Faeth Therapeutics** (NASDAQ:FTH) shares rose 10.13% to $30.0. The company's market cap stands at $702.2 million.
-   **Mobile-health Network** (NASDAQ:MNDR) shares moved upwards by 10.1% to $2.07. The market value of their outstanding shares is at $2.2 million.

### Losers

-   **Cumberland Pharma** (NASDAQ:CPIX) shares declined by 21.0% to $5.28 during Monday's pre-market session. The company's market cap stands at $100.0 million.
-   **Genprex** (NASDAQ:GNPX) shares decreased by 16.87% to $4.98. The market value of their outstanding shares is at $3.0 million.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) stock declined by 11.85% to $3.35. The market value of their outstanding shares is at $2.2 million.
-   **Galmed Pharmaceuticals** (NASDAQ:GLMD) stock declined by 11.44% to $0.55. The company's market cap stands at $5.1 million.
-   **VSee Health** (NASDAQ:VSEE) shares declined by 11.06% to $0.07. The market value of their outstanding shares is at $4.3 million.
-   **Autonomix Medical** (NASDAQ:AMIX) shares decreased by 10.47% to $3.08. The company's market cap stands at $1.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [VSEEW.US](https://longbridge.com/en/quote/VSEEW.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [MNDR.US](https://longbridge.com/en/quote/MNDR.US.md)
- [GNPX.US](https://longbridge.com/en/quote/GNPX.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [VSEE.US](https://longbridge.com/en/quote/VSEE.US.md)
- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)
- [CPIX.US](https://longbridge.com/en/quote/CPIX.US.md)
- [NRXS.US](https://longbridge.com/en/quote/NRXS.US.md)
- [YCBD.US](https://longbridge.com/en/quote/YCBD.US.md)
- [YCBD-A.US](https://longbridge.com/en/quote/YCBD-A.US.md)

## Related News & Research

- [Genprex signs CDMO deal to scale up manufacturing for diabetes gene therapy program](https://longbridge.com/en/news/296218198.md)
- [Mobile-health Network Solutions Advances AI-Powered Lab Data Analysis to Transform Clinical Decision-Making | MNDR Stock News](https://longbridge.com/en/news/295413100.md)
- [Great Lakes Advisors LLC Acquires Shares of 29,800 Supernus Pharmaceuticals, Inc. $SUPN](https://longbridge.com/en/news/296676820.md)
- [Galmed says Colospan intraoperative colon tissue assessment study meets feasibility goal in first-in-human trial](https://longbridge.com/en/news/296343802.md)
- [Autonomix Medical Raises $4.9 Million via Warrant Exercise, Issues New Five-Year Warrants](https://longbridge.com/en/news/297088554.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**